This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Donna French, Ph.D.
Vice President, Dosage Form Design & Development at Astrazeneca

Profile

Donna joined AstraZeneca / MedImmune in June of 2017 as Vice President of the Dosage Form Design and Development organization.  She is responsible for concept-to-product development of drug products and devices for biologics, including formulation sciences, process engineering, novel drug delivery systems, packaging and device development areas that span over three sites in the US and UK.

Prior to AstraZeneca, Donna was Senior Director of Device Development at Genentech and Executive Director of Drug Delivery Engineering at Amgen Inc.  For over 20 years, Donna has been developing and commercializing drug products, drug delivery systems and devices.  She has led the technical development and/or commercialization of numerous biopharmaceuticals with delivery devices worldwide, including auto-injectors, pen injectors, needle stick prevention devices, pre-filled syringes, needle-free injectors, on-body injectors, intraocular delivery devices, inhalation drug delivery systems, smart devices, and patient aids/tools for drug preparation and administration.  Prior to her responsibilities in drug/device combination products, she was a scientist researching novel formulations and formulation-based drug delivery systems for biologics.  Her experience entails research and development of spray-dried formulations for pulmonary drug delivery, crystalline and other particulate suspension formulations, lyophilization formulation and process development and sustained release drug delivery systems. 

Donna received her B.S. in Pharmacy from the Albany College of Pharmacy in Albany, NY in 1988 and a Ph.D. in Pharmaceutical Sciences from the University of Nebraska in 1994.  She is an elected member of the American Institute for Medical and Biological Engineering.

Donna is passionate about creating a positive innovative culture and building high performing organizations.  She is driven to bring the importance of human-centric design of dosage forms to the forefront and create well-designed products that needs of patients and clinicians.

Speakers at this event